Akari Therapeutics Plc - SPONSORED ADR (AKTX)

Q3 2023 13F Holders as of 9/30/2023

Type / Class
Equity / SPONSORED ADR
Number of holders
7
Total Shares
123K
Shares change
+123K
Total reported value, excl. options
$486K
Value change
+$486K
Put/Call ratio
0
Number of buys
7
Number of sells
0
Price
$3.95
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.